Cognitive function in acromegaly: description and brain volumetric correlates (Q48830826)

16 February 2018

title

Cognitive function in acromegaly: description and brain volumetric correlates (English)

1 reference

16 February 2018

author name string

Caroline Sievers

1

1 reference

16 February 2018

P G Sämann

2

1 reference

16 February 2018

H Pfister

3

1 reference

16 February 2018

C Dimopoulou

4

1 reference

16 February 2018

M Czisch

5

1 reference

16 February 2018

J Roemmler

6

1 reference

16 February 2018

J Schopohl

7

1 reference

16 February 2018

G K Stalla

8

1 reference

16 February 2018

J Zihl

9

1 reference

16 February 2018

publication date

1 September 2012

1 reference

16 February 2018

published in

Pituitary

1 reference

16 February 2018

volume

15

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

350-357

1 reference

16 February 2018

Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Serum insulin-like growth factor I in brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Patient selection for IGF-I therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Insulin-like growth factor-1 in plasma and brain: regulation in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Type 2 diabetes and risk of cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Criteria for cure of acromegaly: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Somatic factors in cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0326-Z

Quality of Life (QOL) in Patients with Acromegaly Is Severely Impaired: Use of a Novel Measure of QOL: Acromegaly Quality of Life Questionnaire

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21735089

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21735089

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Insulin-like growth factor-I and cognitive function in healthy older men.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21735089

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11102-011-0326-Z

1 reference

16 February 2018

1 reference

16 February 2018